** Healthcare products provider's shares BIMI.O more than
double to $4.24
** Co says Q2 total rev rose 1,026% to $3.79 mln due to
newly-acquired Guanzan Group's wholesale sales of medical
devices and generic drugs urn:newsml:reuters.com:*:nGNX3GzXfG
** Net income for Q2 was $4.64 mln compared to a net loss of
$862,096 from a year earlier
** BIMI said its acquisition of Guanzan Group this year
allowed it to better function amid the COVID-19 pandemic
** Stock up 4.03% YTD
(Reporting by Madhvi Pokhriyal in Bengaluru)
((Madhvi.pokhriyal@thomsonreuters.com))